Fulgent Genetics, Inc.
FLGT
$18.50
$0.191.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.01% | -254.39% | 65.14% | -64.41% | -95.82% |
| Total Depreciation and Amortization | -1.83% | 1.23% | -0.26% | 2.28% | -4.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.72% | 17.00% | -56.27% | 93.68% | 28.68% |
| Change in Net Operating Assets | 123.37% | -3,107.97% | 106.19% | -293.39% | -160.48% |
| Cash from Operations | 109.08% | -803.55% | 136.81% | -580.91% | -117.71% |
| Capital Expenditure | -4.46% | 17.69% | 11.37% | -44.68% | -24.88% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -100.00% | -- |
| Cash Acquisitions | -- | -100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 344.40% | -24.45% | -64.54% | 85.64% | 237.03% |
| Cash from Investing | -1.93% | -41.55% | -64.26% | 92.59% | 201.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -540.91% | 0.00% | 0.00% | 85.48% | -345.59% |
| Issuance of Common Stock | 800.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -9,805.59% | -25.21% | 86.00% | 75.87% | -4,266.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8,295.69% | -20.00% | 83.13% | 76.39% | -3,316.51% |
| Foreign Exchange rate Adjustments | -96.00% | 400.00% | 275.00% | -63.64% | 108.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.27% | -326.63% | 44.48% | 69.72% | 518.81% |